MINSANTE / DPML DocumentÉdition 2026 — descriptive reference to the selected promotion guide
Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.
Guide de Bonnes Pratiques de la Promotion des Produits Pharmaceutiques — Édition 2026 (selected common provisions for medical devices and reagents) is published by Ministère de la Santé Publique. This document is identified by its title; no separate official document code is recorded.
- Instrument
- Document
- Full name
- Édition 2026 — descriptive reference to the selected promotion guide
- Category
- General
- Source publication
- French with bilingual cover
- Readable HTML
- 1 language version
- Published
- —
- Effective
- —
Open a language version
Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
Guide de Bonnes Pratiques de la Promotion des Produits Pharmaceutiques — Édition 2026 (selected common provisions for medical devices and reagents)
Selected common provisions from the 2026 promotion guide: the cover, glossary and complete operative body. The definitions and scope expressly include medical devices and laboratory or biomedical reagents, subject to the stated marketing authorisation or specific prior ministerial agreement. The source covers promotional-material validation, personnel, vigilance responsibilities, samples, digital promotion, professional interactions and compliance. Medicine-specific wording is retained as context and does not create universal device fees or review deadlines. Separate visa guides and forms remain incompletely reviewed.
This document is identified by its title; no separate official document code is recorded. Always confirm the current consolidated text and transition provisions with the official source before filing.